SG11201601490XA - Risk markers for cardiovascular disease in patients with chronic kidney disease - Google Patents
Risk markers for cardiovascular disease in patients with chronic kidney diseaseInfo
- Publication number
- SG11201601490XA SG11201601490XA SG11201601490XA SG11201601490XA SG11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA SG 11201601490X A SG11201601490X A SG 11201601490XA
- Authority
- SG
- Singapore
- Prior art keywords
- patients
- disease
- chronic kidney
- risk markers
- cardiovascular disease
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 208000020832 chronic kidney disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13182484.9A EP2843056B8 (en) | 2013-08-30 | 2013-08-30 | Risk markers for cardiovascular disease in patients with chronic kidney disease |
| PCT/EP2014/068387 WO2015028612A1 (en) | 2013-08-30 | 2014-08-29 | Risk markers for cardiovascular disease in patients with chronic kidney disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601490XA true SG11201601490XA (en) | 2016-03-30 |
Family
ID=49054458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601490XA SG11201601490XA (en) | 2013-08-30 | 2014-08-29 | Risk markers for cardiovascular disease in patients with chronic kidney disease |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160215341A1 (en) |
| EP (2) | EP2843056B8 (en) |
| JP (1) | JP2016528907A (en) |
| AR (1) | AR097489A1 (en) |
| AU (1) | AU2014314097A1 (en) |
| CA (1) | CA2922329A1 (en) |
| CL (1) | CL2016000447A1 (en) |
| MX (1) | MX2016002529A (en) |
| PE (1) | PE20160603A1 (en) |
| RU (1) | RU2656148C2 (en) |
| SG (1) | SG11201601490XA (en) |
| UY (1) | UY35719A (en) |
| WO (1) | WO2015028612A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108172296A (en) * | 2018-01-23 | 2018-06-15 | 上海其明信息技术有限公司 | A kind of method for building up of database and the Risk Forecast Method of genetic disease |
| CN108897985A (en) * | 2018-05-04 | 2018-11-27 | 上海市内分泌代谢病研究所 | A kind of method and its application of Glycohemoglobin HbA1c genetic locus scoring |
| CN111354464B (en) * | 2018-12-24 | 2024-05-17 | 深圳先进技术研究院 | CAD prediction model establishment method and device and electronic equipment |
| RU2709837C1 (en) * | 2019-03-29 | 2019-12-23 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се | Method for prediction of the probability of intraoperative and early postoperative complications in organ-preserving operations in renal parenchymal tumors |
| CN112034189B (en) * | 2020-06-16 | 2023-03-17 | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | Application of endothelin-1 as marker for evaluating asymptomatic cardiovascular organ damage of primary chronic kidney disease patient |
| CN113643753B (en) * | 2021-05-26 | 2022-07-26 | 中国医学科学院阜外医院 | Multi-gene genetic risk scoring and combined clinical risk assessment application of coronary heart disease |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883750A (en) | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US6159693A (en) | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
| WO2008060618A2 (en) * | 2006-11-15 | 2008-05-22 | University Of Florida Research Foundation | Use of genetic determinants in cardiovascular risk assessment |
| EP2227780A4 (en) * | 2008-03-19 | 2011-08-03 | Existence Genetics Llc | Genetic analysis |
| EP2264183B1 (en) * | 2009-06-09 | 2016-12-07 | Gendiag.exe, S.L. | Risk markers for cardiovascular disease |
| ES2387292B1 (en) * | 2010-06-29 | 2013-10-30 | Fundacio Institut De Recerca Hospital Universitari Vall D'hebron | COMBINATION OF SNPS TO DETERMINE THE RISK OF SUFFERING A NEUROVASCULAR DISEASE |
| HUE029534T2 (en) * | 2011-08-05 | 2017-02-28 | Gendiag Exe Sl | Genetic markers for cardiovascular disease risk assessment |
| WO2013080227A1 (en) * | 2011-11-28 | 2013-06-06 | Decode Genetics Ehf | Genetic variants useful for risk assessment of arterial disease |
-
2013
- 2013-08-30 EP EP13182484.9A patent/EP2843056B8/en not_active Not-in-force
-
2014
- 2014-08-29 AR ARP140103233A patent/AR097489A1/en unknown
- 2014-08-29 AU AU2014314097A patent/AU2014314097A1/en not_active Abandoned
- 2014-08-29 MX MX2016002529A patent/MX2016002529A/en unknown
- 2014-08-29 RU RU2016111308A patent/RU2656148C2/en not_active IP Right Cessation
- 2014-08-29 CA CA2922329A patent/CA2922329A1/en not_active Abandoned
- 2014-08-29 SG SG11201601490XA patent/SG11201601490XA/en unknown
- 2014-08-29 EP EP14758368.6A patent/EP3039156B1/en not_active Not-in-force
- 2014-08-29 WO PCT/EP2014/068387 patent/WO2015028612A1/en active Application Filing
- 2014-08-29 JP JP2016537309A patent/JP2016528907A/en active Pending
- 2014-08-29 PE PE2016000302A patent/PE20160603A1/en not_active Application Discontinuation
- 2014-08-29 UY UY0001035719A patent/UY35719A/en unknown
- 2014-08-29 US US14/914,742 patent/US20160215341A1/en not_active Abandoned
-
2016
- 2016-02-26 CL CL2016000447A patent/CL2016000447A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3039156B1 (en) | 2019-01-02 |
| CL2016000447A1 (en) | 2016-12-09 |
| MX2016002529A (en) | 2016-06-21 |
| AU2014314097A1 (en) | 2016-03-24 |
| AR097489A1 (en) | 2016-03-16 |
| EP3039156A1 (en) | 2016-07-06 |
| EP2843056A1 (en) | 2015-03-04 |
| RU2656148C2 (en) | 2018-05-31 |
| CA2922329A1 (en) | 2015-03-05 |
| US20160215341A1 (en) | 2016-07-28 |
| JP2016528907A (en) | 2016-09-23 |
| EP2843056B8 (en) | 2019-06-26 |
| EP2843056B1 (en) | 2019-04-10 |
| UY35719A (en) | 2015-01-30 |
| WO2015028612A1 (en) | 2015-03-05 |
| PE20160603A1 (en) | 2016-07-03 |
| RU2016111308A (en) | 2017-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2967371A4 (en) | Chronic total occlusion crossing devices with imaging | |
| EP3862044C0 (en) | Dual-tip hemodialysis catheter | |
| EP2967479A4 (en) | Tomosynthesis-guided biopsy in prone | |
| EP2985142A4 (en) | Laminate | |
| HK1222209A1 (en) | Detecting mutations in disease over time | |
| AU350549S (en) | Breathalyzer | |
| HK1223031A1 (en) | Ferric citrate for reducing cardiac failure in chronic kidney disease patients | |
| EP2967598A4 (en) | Hydrodynamic eccentrically pivoting catheter | |
| ZA201605051B (en) | Multiprotease therapeutics for chronic pain | |
| FI20130359L (en) | Tomosynthesis calibration in connection with mammography | |
| CL2016000447A1 (en) | Risk markers for cardiovascular disease in patients with chronic kidney disease. | |
| EP3000600A4 (en) | Laminate | |
| GB2510497B (en) | Catheter | |
| GB201322386D0 (en) | Straight in line | |
| GB201317621D0 (en) | Kidney disease biomarker | |
| EP2948769A4 (en) | Platelet biomarkers in cancer diagnosis | |
| GB2509783B (en) | Foot tracking | |
| PL2875049T3 (en) | Methods for preventing and treating chronic kidney disease (ckd) | |
| GB201305758D0 (en) | Blood Pump | |
| GB201305761D0 (en) | Blood Pump | |
| EP2989589A4 (en) | Validation in serialization flow | |
| ZA201408618B (en) | Disease resistance lociin onion | |
| IL233698B (en) | Multishape catheter | |
| IL245189B (en) | A system for improving the fluid circulation in a fluid-body | |
| PT3007772T (en) | Compositions for use in the treatment of dyslipidaemia in chronic kidney disease |